Targeting the prostate tumor microenvironment and vasculature : the role of castration, tumor-associated macrophages and pigment epithelium-derived factor

Explore this paper's citation graph

Summary

The mainstay treatment for patients with metastatic prostate cancer is castration, a treatment that initially provides symptom-free treatment and stays in the body for at least 12 months after diagnosis.

Type
article
Published
2009-01-01
Cited by
0
References
185
Access
Open access

Keywords

Prostate, Epithelium, Tumor microenvironment, Prostate cancer, Pathology

References

Cited by

No citing papers recorded for this paper.

Related papers